| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |